Publication | Closed Access

Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-κB inhibitor, DMAPT (LC-1)

Molecular PharmacologyMedicinal ChemistryNf-κb InhibitorNovel Anti-leukemic AgentsMedicineImmunologyPeptide TherapeuticsPharmacotherapyAnti-cancer AgentPharmacologyPharmaceutical ChemistryNovel TherapyDrug Discovery